KRSNAANSEAugust 16, 2021

Krsnaa Diagnostics Limited

2,645words
6turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
O GOOD ... ® Date: 23rd March, 2022 BSE Ltd. Corporate Service Department l51 Floor, P.J. Towers, Dalal Street, Mumbai 400 001 Scrip ID: l<RSNAA Scrip Code: 543328 Dear Sir/Madam, The Nation
29 Million
orporated Aug-21 Listing at BSE and NSE 1,900+ Diagnostics Centre 14 States Presence in India 29 Million Patients Served Since Inception Krsnaa Diagnostics is one of the fastest growing and differentiat
Rs. 347
ionals including clinicians, technicians and operators Notes: 1. Operational KPI’s as of Dec 2021 Rs. 347 Cr 9M FY22 Revenue Rs. 105 Cr | 30% 9M FY22 EBITDA and Margins 1,900+ Diagnostics Centre Rs. 50
Rs. 105
technicians and operators Notes: 1. Operational KPI’s as of Dec 2021 Rs. 347 Cr 9M FY22 Revenue Rs. 105 Cr | 30% 9M FY22 EBITDA and Margins 1,900+ Diagnostics Centre Rs. 50 Cr | 14% 9M FY22 PAT and Ma
30%
and operators Notes: 1. Operational KPI’s as of Dec 2021 Rs. 347 Cr 9M FY22 Revenue Rs. 105 Cr | 30% 9M FY22 EBITDA and Margins 1,900+ Diagnostics Centre Rs. 50 Cr | 14% 9M FY22 PAT and Margins 3
Rs. 50
s. 347 Cr 9M FY22 Revenue Rs. 105 Cr | 30% 9M FY22 EBITDA and Margins 1,900+ Diagnostics Centre Rs. 50 Cr | 14% 9M FY22 PAT and Margins 3 Fastest Growing Diagnostic Chain In India Fastest growing dia
14%
FY22 Revenue Rs. 105 Cr | 30% 9M FY22 EBITDA and Margins 1,900+ Diagnostics Centre Rs. 50 Cr | 14% 9M FY22 PAT and Margins 3 Fastest Growing Diagnostic Chain In India Fastest growing diagnostic
rs 2017
anges 2013 2018 2020 August 16, 2021 2011 Incorporated the Company with two radiology centers 2017 Expanded footprint Centres – 50 States – 4 2019 Expanded strategic tie-up with Private Hospita
36x
res – 50 States – 4 2019 Expanded strategic tie-up with Private Hospital Private Centres – 14 36x Growth in Centres 2021 Expansion Centres – 1,800+ States – 14 Won contract for Punjab Radiol
78%
ucture, large scale of operations and cost competitiveness have resulted in strong bid-win rate of 78% in the past and trend is expected to continue  Ability to quote attractive pricing at the time o
3.2x
es Headroom CT Scans 126,000 4,79,233 MRIs X-Rays 31,500 1,45,116 1,500,000 24,29,683 3.2x 2.6x 7.4x 6 Existing Extensive Footprint and Infrastructure (Excluding Punjab & HP PPP Proje
2.6x
droom CT Scans 126,000 4,79,233 MRIs X-Rays 31,500 1,45,116 1,500,000 24,29,683 3.2x 2.6x 7.4x 6 Existing Extensive Footprint and Infrastructure (Excluding Punjab & HP PPP Projects) R
Guidance — 1 items
Notes
opening
Mn) 67% CAGR 1,884 2,676 2,317 Revenue (Rs.
Advertisement
Risks & concerns — 1 flagged
He had served other companies including XEROX India, Glyph International • As an Independent Director, he serves as the Chairman of the Nomination and Remuneration Committee as well as Stakeholders’ Relationship Committee and also as a member of the Audit Committee and Risk Management Committee Prakash Iyer Independent Director • B.Tech in Mechanical Engineering from IIT Delhi and a PGDM from IIM Calcutta • Over 40 years of experience.
Notes
Speaking time
Notes
2
Note
2
For further information please contact
1
Contact us
1
Advertisement
Opening remarks
Notes
1. Operational KPI’s as of Dec 2021 Rs. 347 Cr 9M FY22 Revenue Rs. 105 Cr | 30% 9M FY22 EBITDA and Margins 1,900+ Diagnostics Centre Rs. 50 Cr | 14% 9M FY22 PAT and Margins 3 Fastest Growing Diagnostic Chain In India Fastest growing diagnostic chain in India, offering high quality services at disruptive prices Started operating 12 centres in Himachal Pradesh in public private partnership Pan India Expansion Centres – 664 States – 12 Expansion Centres – 1,300+ States – 13 Listing on the Stock Exchanges 2013 2018 2020 August 16, 2021 2011 Incorporated the Company with two radiology centers 2017 Expanded footprint Centres – 50 States – 4 2019 Expanded strategic tie-up with Private Hospital Private Centres – 14 36x Growth in Centres 2021 Expansion Centres – 1,800+ States – 14 Won contract for Punjab Radiology 4 Krsnaa Competitive Advantages Sustainable business model backed by underlying competitive advantages and well positioned to drive growth 1 2 3 4 5 Revenue Visibility  Long-term of
Note
1. Data as of March 22 10 Diagnostics Centres Rollout Plan on Track High quality infrastructure and services at disruptive prices creates market awareness and drives direct walk-ins Branding at Centres “Media coverage of Krsnaa Diagnostics center in Punjab – highlighting best in class infrastructure at disruptive prices along with best-in-class quality.” World Class Infrastructure 11 Digitalization and Transformation Fully Integrated IT Infrastructure Driving Operational Efficiency at All Levels Information Management System Stores and manages all diagnostic data, including all patient demographic and medical diagnostics information - allows real time tracking of specimen collection, shipping and testing Picture Archiving and Communications System Ensures lossless compression and transmission of images. It operates on broadband, 2G and 3G networks and capable of rapid deployment and easy integration for operational requirements Digital Dashboarding Real-time patient and testing informa
Notes
1. Profit After Tax is calculated without exceptional Items 13 Experienced Leadership Team • 10+ years of experience in the field of pharmacy and diagnostics • Registered pharmacist certified by the Maharashtra State Pharmacy Council Rajendra Mutha Executive Chairman • 8 years of experience in the field of diagnostic services • Responsible for expansion and growth • Pallavi Bhatevara, Managing Director Involved in the tendering process and implementation and execution of projects Yash Mutha Whole Time Director • 12+ years of experience in the field of audit and risk management • CA, CISA, CFE • Previously associated with KPMG, Deloitte, Credit Suisse • 24+ years of experience in the field of business management and transforming organizations • Doctorate, Business Administration and Management from Azteca University, Mexico • PGDBM in Sales & Management, a commerce graduate from Delhi University Ravinder Sethi Chief Operating Officer • 14+ years of experience in the field of Pathology s
Note
1. Leadership Team members, Rajendra Mutha is the Executive Director and Chairman, Pallavi Bhatevara is the Executive Director and Managing Director, Yash Mutha is the Executive Director. 15 Diversified Business – Expanding B2C Capitalizing on the extensive infrastructure of Pathology Diagnostics and extending it to end consumers 537 Pathology Centres 46 491 Processing Labs Collection Centres  Planning to launch in FY23, B2C pathology diagnostic service offerings at disruptive prices in 4 states i.e.. Maharashtra, Punjab, Himachal Pradesh and Jammu & Kashmir Plan is to open 1,000 collection centres in these states  Capitalizing on the existing infrastructure of Pathology centres  Further expand B2C in other remaining states and adding more collection centres to penetrate deeper into key markets  B2C to enhance overall operational efficiencies 16 Key Takeaways Target is to achieve 2x growth in Revenues and 3x growth in Profits in next three years One of the Fastest Growing Diagnosti
For further information please contact
Krsnaa Diagnostics NIkhil Deshpande, Company Secretary cs@krsnadiagnostics.com Contact: +91 20 4695 4695 Churchgate Partners Ravi Gothwal / Vikas Luhach, krsnaa@churchgatepartners.com Contact: +91 22 6169 5988 18
Contact us
Krsnaa Diagnostics Ltd. S.No.243,A-Hissa No.6/6 CTS No.4519, Near Mayur Trade Centre, Chinchwad, Pune, India - 411 019
Advertisement
← All transcriptsKRSNAA stock page →